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Abstract. Background: Chronic heart failure (CHF) is an inflammatory disorder in which cortisol 
plays an important role. Despite this, cortisol is not routinely quantitatively measured for a number 
of reasons. It is considered non-specific. Accuracy and validity remain in question. It is not 
considered convenient or cost effective. Finally, tissue level effects of cortisol do not correlate 
linearly to quantitative levels. If the functional, tissue level effectiveness of cortisol could be 
modeled, its evaluation in CHF patient may become relevant. Endobiogeny is a global systems 
theory that claims to be able to model complex physiology through biomarkers, offering context-
rich interpretations of data for meaningful clinical applicability. Cortisol is known to alter 
circulating levels of elements from a complete blood count (CBC). By relating these biomarkers 
in a qualitative fashion, the theory of Endobiogeny posits that these elements can be contextualized 
to reflect the tissue level activity of cortisol, referred to as the cortisol index (CI). The algorithm 
derived from the theory is called the Biology of Functions (BoF). Aim: The aim of this study was 
to determine if the cortisol index is accurate in reflecting a greater expression of cortisol activity 
in ambulatory CHF patients versus controls subjects. Methods: A retrospective observational case 
control study was performed in 93 patients with New York Heart Association class II-III heart 
failure patients and 104 individuals with no cardiovascular pathology as a control group. Results 
from a CBC were entered into BOF modeling software, from which the cortisol index is derived. 
Results: The Cortisol index (3-7) was significantly elevated in CHF vs. control patients (12.8±0.91 
vs. 8.48±0.74, 𝑝 < 001), as were individual CBC elements used to form the index. Conclusions: 
The cortisol index, derived from the theory of Endobiogeny showed results consistent with CHF 
pathophysiology. The cortisol index was able to model the effective tissue level activity of cortisol 
in CHF patients using only a CBC, without measuring serum cortisol. Future studies should 
compare the cortisol index to standard inflammatory markers in CHF patients to further correlate 
the validity of the index to other known effects of cortisol. 
Keywords: systems biology, biological markers/analysis, hormones, metabolism, heart failure, 
humans. 
1. Introduction 
Cortisol is a key hormone involved in the adaptation response. Its role in the pathophysiology 
of chronic heart failure (CHF) is well characterized [1-3]. Elevated serum cortisol is correlated 
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with morbidity and mortality in CHF. Despite this, it is not routinely evaluated for four reasons: 
clinical utility, convenience, convention and accuracy. If these issues can be addressed, cortisol 
assessment may prove to be of value in CHF patients. 
Perceived lack of clinical utility of cortisol evaluation arises from three considerations: 
emphasis on downstream biomarkers, lack of specificity and absence of pharmacologic treatment. 
Over the last few decades, research has focused on increasingly downstream markers of CHF 
pathophysiology, e.g. interleukin-6 and matrix metalloproteinase (MMP) [4]. From this 
perspective, cortisol is seen as too far upstream to be of value. Early research in CHF was oriented 
towards a systems approach [2, 3]. Since CHF is a multisystem dysfunction, returning to this 
approach of studying upstream mediators may be beneficial. 
Cortisol lacks specificity in CHF. In contrast, brain-derived natriuretic peptide (BNP) is 
tissue-specific, correlating to severity of disease and mortality [4]. However, CHF influences and 
is influenced by vascular, renal, pulmonary, endocrine and autonomic dysfunction, not just 
myocardial dysfunction. Since cortisol affects all these factors in CHF patients, [1, 5] evaluating 
the constitutive role of cortisol may be more valuable in managing patients than only investigating 
markers of myocardial dysfunction.  
Finally, despite extensive research, no commercially available pharmacologic treatments are 
available to reduce cortisol [6]. However, the same can be said for IL-6, MMP and BNP. 
Furthermore, unlike downstream markers, non-pharmacologic interventions have been shown to 
lower cortisol in various clinical conditions, including cardiovascular disease [7-9].  
Convenience is the second reason cortisol is not routinely evaluated in CHF. Serum cortisol 
tests are neither routine nor rapid. Furthermore, the validity of morning vs. random cortisol blood 
draws has not been satisfactorily established [10]. Convention is the third reason. Hormone 
assessment is considered the domain of endocrinologists, not cardiologists. However, 
cardiologists manage cardiac disease through regulation of neuroendocrine factors viz. inhibitors 
of adrenaline, aldosterone, angiotensin, etc. Longitudinal evaluation of cortisol would be within 
the scope of clinical cardiology if it were proven to have diagnostic or predictive value in CHF.  
Accuracy and validity are the third reason cortisol is not routinely evaluated. Discoveries in 
molecular endocrinology have raised questions regarding the value of quantitative serum cortisol 
measurement. Cortisol’s actions can be genomic or non-genomic [11]. Many non-genomic actions 
of cortisol are permissive, [12] viz. sequestration of inflammatory immune elements, and 
improved cardiac function [11, 13, 14]. Genomic effects involve several mechanisms for which 
genetic polymorphisms and epigenetic influences can alter efficiency and activity of cortisol 
[5, 11]. Genomic effects are primarily adaptive, acting via NF-κB up-regulation [11]. These 
adaptive actions of cortisol are the ones association with severity of CHF. In summary, a 
quantitative assessment of serum cortisol may not be a reliable indicator of its downstream 
functional effects on metabolism.  
The theory of endobiogeny is a global systems approach to integrative physiology [15]. As 
such, it favors evaluation of upstream causes of pathophysiology – such as cortisol – over 
downstream mechanisms of disease such as IL-6, MMP and BNP. From the theory of endobiogeny 
a physiologic modeling system has been derived called the biology of functions (BoF). 
Biomarkers are viewed as downstream products of cellular metabolism and thus indirect markers 
of upstream regulation of cell and tissue metabolism [16]. The applicability of this global systems 
approach in CHF patients was recently demonstrated with respect to the neutrophil-to-lymphocyte 
ratio, referred to as the Genito-thyroid index in Endobiogenic terminology [17].  
It is claimed by proponents of the theory Endobiogeny that the functional activity of cortisol 
can be modeled without measuring cortisol in any body fluid [16]. An index has been developed 
called the Cortisol index (CI). The proprietary formula is derived from published studies on the 
action of cortisol on bone marrow and its cellular elements in circulation. Thus, the theory takes 
the effects of cortisol on a single type of tissue – bone marrow – and extrapolates this to consider 
the global functional effects of cortisol on all tissues. 
Cortisol increases production and circulating levels of leukocytes in general, and neutrophils 
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in particular. It diminishes circulating levels of lymphocytes and eosinophils through sequestration 
and apoptosis. We have evaluated these studies in detail elsewhere [16]. The cortisol index 
formula then incorporates the bone marrow products that are increased in the numerator, and those 
that are diminished by cortisol in the denominator. In the context of heart disease, these changes 
in the CBC have already been characterized, [17, 18] but not evaluated simultaneously according 
to a global systems perspective until now.  
We hypothesized that the modeling system of endobiogeny would demonstrate elevated values 
of the cortisol in ambulatory CHF patients versus controls.  
2. Methods 
2.1. Study participants  
One hundred and four control subjects were recruited with no history of cardiovascular 
pathology, and ninety-three subjects with New York Heart Association (NYHA) classes II through 
III heart failure were recruited from the San Diego Veterans Affairs Medical Center Cardiology 
Clinic and the University of California, San Diego (UCSD) Medical Center Advanced Heart 
Failure Program for this retrospective observational case-controlled study. They were part of a 
larger study in subjects with heart failure in which the effects of depression on cellular adhesion 
and inflammation was being investigated. We included the non-CHF control sample from the local 
community via advertisements (e.g., newspapers, flyers, brochures, and websites) and word of 
mouth referrals. 
The first inclusion criteria were age between 30 and 85 years. Additional inclusion criteria for 
non-control subjects were optimal standard management of heart failure for three months or  
longer. As part of the patient’s routine medical evaluation, left ventricular ejection fraction  
(LVEF) was assessed by echocardiography. Exclusion criteria included recent history of 
myocardial infarction, stroke or significant cerebral neurological impairment within the past 
month. Other criteria included presence of severe chronic obstructive pulmonary disease, 
psychiatric illness (other than depression), or anxiety. Subjects were asked to avoid aspirin for 1 
day before testing. 
The investigation conformed to the principles outlined in the Declaration of Helsinki. The 
University of California, San Diego Institutional Review Board, approved the study. All subjects 
gave informed written consent.  
2.2. Biochemical analyses  
For complete blood count with differential and platelets, blood was drawn into 
ethylenediaminetetraacetic acid (EDTA)-coated vacutainer tubes (BD Biosciences, San Jose, 
California). The Clinical Laboratory at the UCSD Medical Center resulted all blood samples. 
2.3. Value of indices 
The normal value of the cortisol index for adults is 3-7. The indices of the biology of functions 
(BoF) are ratios or relative physiologic activity, therefore they contain no units of value. They 
were derived through internal research on healthy vs. non-healthy populations of Western 
European origin. 
The BoF models both structure vs. function values. The Cortisol index contains both structure 
and function values. Structure values evaluate basil function. Function values model adaptive 
activity. In this population of CHF patients, the function value of cortisol was used, since we 
theorize CHF to be a functional adaptation disorder of the myocardium.  
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2.4. Statistical analyses  
Using the Kolmogorov-Smirnov test, normal distribution of data was verified prior to 
statistical analyses for both groups. Data for cortisol and eosinophils underwent log  
transformation. We calculated mean arterial pressure (MAP) and body mass index (BMI) using 
standard formulas. Data are presented as mean±standard distribution. Results were considered 
statistically significant at the 𝑝 ≤ 0.05 level. Using Pearson correlation, the relationship among 
variables was tested and by analysis of variance the groups were compared. All calculations were 
performed using SPSS Inc. (version 24.0) software package (SPSS, Chicago, Illinois). 
In Table 1, sociodemographic and medical characteristics of the study participants are  
presented. Heart failure patients were older (𝑝 < 0.01) and with greater BMI (𝑝 < 0.01) than 
non-HF subjects. Heart failure patients also had lower mean blood pressure (𝑝 < 0.01). 
Table 1. Sociodemographic and medical characteristics of the study subjects  
Mean (SD) Heart failure Non-heart failure 
𝑁 93 104 
Age (years) * 55.9 (12) 49.2 (14) 
Gender (#Women / #Men) 15 / 78 12 / 92 
Body Mass Index [kg/m2] * 31.9 (8.2) 28.8 (6.4) 
Mean arterial pressure [mm Hg] ** 80.0 (9.5) 90.5 (10.1) 
LVEF (%)  32.1%  – 
Medications 
ACE inhibitors 73 % 0 % 
Beta blockers 95 % 0 % 
Calcium channel blockers 5 % 0 % 
Statin 56 % 0 % 
Aspirin 54 % 7 % 
Diuretics 90 % 0 % 
Anti-arrhythmics 9 % 0 % 
Digoxin 61 % 0 % 
*𝑝 < 0.01, **𝑝 < 0.001 
The Cortisol index was significantly different between HF and control (12.8±0.91 vs. 
8.48±0.74, 𝑝 < 001). Evaluation of the individual components of the CBC with differential and 
the genito-thyroid index (neutrophil/lymphocytes) demonstrated a significant correlation for all 
components except eosinophils (Table 2). 
Table 2. ANOVA of heart failure vs. control 
Variable Normal range HF Control Combined F value DF Partial Eta2 
Cortisol index* 3-7 12.8±8.5 8.48±7.4 10.5±8.2 15.87 1.188 0.078 
WBC* 5000-8500/μL 6.952±1.725 5.791±1.456 6.339±1.687 26.18 1.195 0.118 
Neutrophils* 45-55 % 62±10 58±8 60±9 12.94 1.195 0.062 
Lymphocytes* 35-45 % 25±9 30±7 28±8 18.92 1.195 0.088 
Eosinophils** 1-5 % 3.57±3.6 3.32±2.4 3.44±3.1 0.427 1.195 0.002 
*𝑝 < 0.001, **𝑝 = 0.5; DF = degree of freedom 
There was a significant positive association between the cortisol index total WBC count and 
percent neutrophils on differential, and significant negative association with percent lymphocytes 
and eosinophils on differential (Table 3).  
The relationship between various elements of the CBC used to compose the cortisol index was 
compared for the all patients (HF and control). There was a significant positive correlation 
between total WBC count and the relative percentage of neutrophils and lymphocytes, but not too 
percent eosinophils (Table 4). There was a significant negative correlation between percent 
neutrophils and both eosinophils and lymphocytes (Table 4). 
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Table 3. Pearson correlation per group 
Cortisol index WBC Neutrophils Lymphocytes Eosinophils 
HF (𝑛 = 89) 0.420* 0.678* –0.510* –0.708* 
Control (𝑛 = 101) 0.370* 0.536* –0.424* –0.735* 
Combined (𝑛 = 190) 0.450* 0.633* –0.520* –0.676* 
*𝑝 < 0.001; WBC: white blood cell 
Table 4. Pearson correlation of the CBC with differential  
 WBC Neutrophils Lymphocytes Eosinophils 
WBC 1 0.463* –0.420* –0.119** 
Neutrophils 0.463* 1 –0.906* –0.281* 
*𝑝 < 0.001, **𝑝 > 0.05 
3. Discussion 
In this retrospective study, we evaluated the validity of a formula that models the effective 
tissue level activity of cortisol in patients with CHF. We found the mean value of the Cortisol 
index (CI) higher in CHF patients compared to controls. This is in accordance with over 50 years 
of research in this patient population [1-3]. In general, patients with cardiovascular disease are 
more sensitive to glucocorticoids than control subjects.  
At this time there is consensus neither on which body fluid is the most appropriate source of 
measurement nor how accurate or valid quantitative measurement of cortisol may be. Stricto senso, 
it only evaluates metabolic output from the adrenal cortex. Thus, it is suggestive of potential tissue 
activity but not its actual achieved effects, [10] which depend on a myriad of genetic and 
epigenetic factors [5, 15, 16]. Fasting plasma cortisol may not be a reliable indicator of tissue-level 
cortisol activity [5]. Salivary or urinary cortisol may be more representative of this as a posteriori 
measurement of cortisol movement through tissues, but they are not routinely evaluated [10]. 
Some studies have found salivary – not serum – cortisol predictive of all-cause mortality in  
general, once again raising questions about the value of serum cortisol evaluation [19].  
The advantage of the cortisol index according to the theory of Endobiogeny is that it is easily, 
rapidly and inexpensively calculated from a completed blood count with differential and platelets. 
This test is commonly performed in ambulatory CHF patients. Because it models net global 
functional activity, it is not dependent on circadian rhythms and can be drawn at any time. It can 
be repeatedly performed even within hours of prior samples to evaluate the evolution of cortisol 
activity in acute and chronic settings [16, 17]. 
In this study, elements of a CBC affected by cortisol were found to have statistical significance 
with the cortisol index. However, no single element of a CBC alone could be used to evaluate 
cortisol activity. Furthermore, when evaluating the relationship between individual components 
of the formula, both the qualitative relationship of percent leukocytes (neutrophils, leukocytes and 
eosinophils) and the total, quantitative assessment of white blood cells was required to properly 
account for all the influences on the formula. We find that this supports the Endobiogenic theory 
that it is in both quantitative and qualitative assessments that physiologic activity can be best 
characterized.  
There are limitations to this study. The index selects a single tissue: bone marrow as 
representative of all tissues in which cortisol has an effect. This assumption has not been validated 
though we are not sure how it could be because of the lack of biomarkers as relatively easily 
obtained as those from the bone marrow. Furthermore, the crucial and foundational role of marrow 
and the elements immunity, oxygenation and thrombosis that it produces makes it the essential 
and constitutional tissue.  
The study was retrospective in nature and the prognostic role of cortisol or the cortisol index 
could not be determined. The cortisol index was not compared to quantitative measurements of 
cortisol by serum, saliva or urine. However, as we have discussed above, it is not clear how valid 
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these measurements would be as a “gold standard” of cortisol activity. Future studies should be 
prospective in nature to evaluate the prognostic value of the cortisol index. 
As a stand-alone index, the cortisol index may prove to be of value in evaluating one aspect of 
CHF physiology. The biology of functions incorporates the cortisol index into meta-indexes that 
purport to model complex states and events affected by cortisol such as inflammation and risk of 
arterial wall damage and thrombolysis [16]. Future studies will need to validate these claims. 
4. Conclusions 
This study demonstrated for the first time that tissue-level actions of cortisol can be modeled 
based on the know effects of cortisol on a CBC with differential according to a global systems 
approach based on the theory of Endobiogeny. A positive correlation was shown between mean 
cortisol in ambulatory patients with stages 2 or 3 CHF versus control subjects. The cortisol index 
appears to meet all the criteria hypothesized at the outset for the ideal marker of cortisol activity: 
rapid, inexpensive and quantitative assessment of the qualitative effects of cortisol on tissue.  
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